GeneDx (WGS) PT Lowered to $55 at TD Cowen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall St set for steady open as oil jumps ahead of key earnings
- Oil prices rise as attacks on Saudi Arabia overshadow Trump's Russian supply announcements
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- Iren shares jump 5% in premarket trade on report of Anthropic AI cloud deal
Tweet
Share
E-mailGet Alerts WGS Hot Sheet
Price: $67.33 --0%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 20 | New: 46
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 20 | New: 46
Join SI Premium – FREE
TD Cowen analyst Dan Brennan lowered the price target on GeneDx (NASDAQ: WGS) to $55.00 (from $90.00) while maintaining a Buy rating.
You May Also Be Interested In
- Delta Air Lines (DAL) PT Lowered to $102 at UBS, Buy Rating Maintained
- Ford (F) PT Lowered to $16 at JPMorgan Into Q3 Earnings
- Western Digital Corp. (WDC) PT Lowered to $470 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
